Elanco Animal Health, Inc. (ELAN)
23.92
-0.19
(-0.79%)
USD |
NYSE |
Aug 31, 16:00
23.92
0.00 (0.00%)
Pre-Market: 20:00
Elanco Animal Health Cash from Operations (TTM) : 617.00M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 617.00M |
| March 31, 2026 | 577.00M |
| December 31, 2025 | 560.00M |
| September 30, 2025 | 629.00M |
| June 30, 2025 | 572.00M |
| March 31, 2025 | 535.00M |
| December 31, 2024 | 541.00M |
| September 30, 2024 | 521.00M |
| June 30, 2024 | 557.00M |
| March 31, 2024 | 418.00M |
| December 31, 2023 | 271.00M |
| September 30, 2023 | 127.00M |
| June 30, 2023 | 118.00M |
| March 31, 2023 | 369.00M |
| December 31, 2022 | 452.00M |
| September 30, 2022 | 662.00M |
| Date | Value |
|---|---|
| June 30, 2022 | 562.00M |
| March 31, 2022 | 399.00M |
| December 31, 2021 | 483.00M |
| September 30, 2021 | 167.10M |
| June 30, 2021 | -33.60M |
| March 31, 2021 | -23.30M |
| December 31, 2020 | -41.00M |
| September 30, 2020 | 178.20M |
| June 30, 2020 | 329.50M |
| March 31, 2020 | 222.80M |
| December 31, 2019 | 224.10M |
| September 30, 2019 | 237.30M |
| June 30, 2019 | 361.60M |
| March 31, 2019 | 445.90M |
| December 31, 2018 | 487.30M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Zoetis, Inc. | 2.887B |
| Eli Lilly & Co. | 28.08B |
| ANI Pharmaceuticals, Inc. | 189.47M |
| EyePoint, Inc. | -267.30M |
| Amylyx Pharmaceuticals, Inc. | -126.58M |